×
About 1,923 results

ALLMedicine™ Insulin Pumps Center

Research & Reviews  461 results

Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents
https://clinicaltrials.gov/ct2/show/NCT05300022

Aug 11th, 2022 - Despite increased use of insulin pumps and continuous glucose monitors (CGM) for pediatric type 1 diabetes (T1D) management and research studies showing benefits from the use of these devices, real-world glycemic control among youth with T1D has w...

Do-it-yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An...
https://doi.org/10.1016/j.jcjd.2022.06.003
Canadian Journal of Diabetes; Morrison AE, Senior PA et. al.

Aug 10th, 2022 - In the past century, since the discovery of insulin, methods of insulin delivery and glucose monitoring have advanced technologically. In particular, the introduction of insulin pumps, providing continuous subcutaneous insulin infusion (CSII), and...

Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1
https://clinicaltrials.gov/ct2/show/NCT04271228

Aug 9th, 2022 - The DreaMed Advisor Pro, is a software which automatically analyses treatment information, learns patient's needs and accordingly suggests adjustments in insulin dosing (FDA approved decision support system). The Advisor Pro uses information gathe...

Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump
https://clinicaltrials.gov/ct2/show/NCT05299177

Aug 8th, 2022 - Self-management of type 1 diabetes is challenging, efforts to optimise time spent in the target range can result in hypo- and hyperglycaemia. Structured education, glucose monitoring and advances in insulin delivery can increase time in range and ...

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)
https://clinicaltrials.gov/ct2/show/NCT04902378

Aug 8th, 2022 - Pregnant women with type 1 diabetes (T1D) require normal or near normal glucose in order to reduce the risks of birth defects, stillbirth, increased birthweight, neonatal hypoglycemia, neonatal death, preterm delivery and preeclampsia. Reducing ma...

see more →

Guidelines  2 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Ass... Choudhary P, Campbell F et. al.

Feb 19th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American Col... Grunberger G, Handelsman Y et. al.

Mar 17th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  77 results

Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents
https://clinicaltrials.gov/ct2/show/NCT05300022

Aug 11th, 2022 - Despite increased use of insulin pumps and continuous glucose monitors (CGM) for pediatric type 1 diabetes (T1D) management and research studies showing benefits from the use of these devices, real-world glycemic control among youth with T1D has w...

Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1
https://clinicaltrials.gov/ct2/show/NCT04271228

Aug 9th, 2022 - The DreaMed Advisor Pro, is a software which automatically analyses treatment information, learns patient's needs and accordingly suggests adjustments in insulin dosing (FDA approved decision support system). The Advisor Pro uses information gathe...

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)
https://clinicaltrials.gov/ct2/show/NCT04902378

Aug 8th, 2022 - Pregnant women with type 1 diabetes (T1D) require normal or near normal glucose in order to reduce the risks of birth defects, stillbirth, increased birthweight, neonatal hypoglycemia, neonatal death, preterm delivery and preeclampsia. Reducing ma...

Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump
https://clinicaltrials.gov/ct2/show/NCT05299177

Aug 8th, 2022 - Self-management of type 1 diabetes is challenging, efforts to optimise time spent in the target range can result in hypo- and hyperglycaemia. Structured education, glucose monitoring and advances in insulin delivery can increase time in range and ...

MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT03945747

Aug 1st, 2022 - Background: Over 1.25 million Americans have type 1 diabetes mellitus (T1DM), significantly increasing the risk of early death from cardio-renal disease. Per the American Diabetes Association, only 14% of children with T1DM meet glycemic targets [...

see more →

News  228 results

Closing the Gap on Diabetes Care in Minority Populations
https://www.medscape.com/viewarticle/977616

Aug 9th, 2022 - This transcript has been edited for clarity. Hello, everyone. As you might be aware, there's a big disparity gap in diabetes care in the minority population, including Latinos. I am a pediatric endocrinologist at the Barbara Davis Center, where we...

Isocyanates Linked to Allergic Contact Dermatitis From Diabetes Devices and Wound Dressings
https://www.medscape.com/viewarticle/978822

Aug 8th, 2022 - Isocyanate adhesives found in polyurethane (PU)–based diabetes devices and wound dressings may cause allergic contact dermatitis (ACD), results of a small case series suggest. "Isocyanates, widely used in the production of paints, coatings, glues,...

The Team Approach to Managing Type 2 Diabetes
https://www.mdedge.com/type-2-diabetes-icymi/article/256290/diabetes/team-approach-managing-type-2-diabetes
Rozalina G. McCoy, MD, MS

Jul 25th, 2022 - Those of us who treat patients with type 2 diabetes (T2D) daily have long recognized a disturbing irony: diabetes is a disease whose management requires consistency in approach and constancy in delivery, but it is most prevalent among those whose.

Turn 'Patients Into Experts' on Their Diabetes With CGM Use
https://www.medscape.com/viewarticle/975637

Jul 15th, 2022 - This transcript has been edited for clarity. Continuous glucose monitoring (CGM) is revolutionizing the way we look at diabetes. We've gone from a 30,000-foot view in diabetes to an individualized, patient-centric glucose- or diabetes-related jour...

Diabetes Devices May Give Kids Contact Dermatitis
https://www.medscape.com/viewarticle/976416

Jun 30th, 2022 - Devices that help children control their diabetes and lead fuller lives may also give them contact dermatitis, report the authors of a new study that calls for mandatory labeling of ingredients for allergy patch testing. "A high share of patients ...

see more →